US Autoinjectors Market: Growth Momentum Driven by Biologics, Patient-Centric Care, and Regulatory Support
The US autoinjectors market is undergoing a transformational expansion, fueled by rising adoption of self-administered biologics, strong reimbursement structures, and continuous innovation in device design. The market, valued at US$0.65 billion in 2024, is projected to reach US$1.45 billion by 2030, exhibiting a robust CAGR of 14.2%. In parallel, the autoinjector finished formulations market—covering...